Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
09/09/2004 | US20040175812 Carbohydrates and polyols for dissolving protein crystals |
09/09/2004 | US20040175803 Interferon-alpha induced gene |
09/09/2004 | US20040175798 Expression system for recombinant proteins |
09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
09/09/2004 | US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering |
09/09/2004 | US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction |
09/09/2004 | US20040175766 Human pyrimidine receptor |
09/09/2004 | US20040175730 Comprises nucleotide sequences coding polypeptide associated with vascular permeability or proliferation of endothelial cells for treating intestinal malabsorption syndrome |
09/09/2004 | US20040175714 Human protooncogene kg-20 and protein encoded therein |
09/09/2004 | US20040175395 Contains connecting disulfide bridge; humanized monoclonal and polyclonal antibodies; diagnostic kits for respiratory syncytial virus |
09/09/2004 | DE10309691A1 Isolating cytosol-dissolved proteins from cells of recombinant microorganisms includes precipitating unwanted materials with a cationic surfactant |
09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
09/08/2004 | EP1454140A2 Diagnosis and treatment of atherosclerosis |
09/08/2004 | EP1453981A1 Methylotrophic bacterium for the production of recombinant proteins and other products |
09/08/2004 | EP1453977A2 Molecular characteristics of non-small cell lung cancer |
09/08/2004 | EP1453966A1 Method for producing a recombinant polypeptide |
09/08/2004 | EP1453963A2 A structure for presenting desired peptide sequences |
09/08/2004 | EP1453956A1 Method for large scale production of virus antigen |
09/08/2004 | EP1453954A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
09/08/2004 | EP1453952A2 Compositions and methods for normalizing assays |
09/08/2004 | EP1453948A2 Cell culture process |
09/08/2004 | EP1453858A1 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
09/08/2004 | EP1453857A1 Chromatographic purification of recombinant human erythropoietin |
09/08/2004 | EP1453856A1 Beta-amyloid binding factors and inhibitors thereof |
09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
09/08/2004 | EP1453854A2 Human cdnas and proteins and uses thereof |
09/08/2004 | EP1453848A2 Sir2 products and activities |
09/08/2004 | EP1453543A2 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
09/08/2004 | EP1453534A1 A process for the preparation of a non-toxic anthrax vaccine |
09/08/2004 | EP1453383A2 A novel saitohin gene and uses of same |
09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
09/08/2004 | EP1341802A4 In vitro protein synthesis using glycolytic intermediates as an energy source |
09/08/2004 | EP1087995B1 A method for inducing production of growth factors |
09/08/2004 | EP1017802B1 A potential effector for the grb7 family of signalling proteins |
09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
09/08/2004 | EP0873405B1 Expression augmenting sequence elements (ease) for eukaryotic expression systems |
09/08/2004 | EP0763009B1 Photocleavable conjugates for the detection and isolation of biomolecules |
09/08/2004 | EP0739355B1 Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
09/08/2004 | CN1527941A Methods using 06-alkylguanine-DNA alkyltransferase |
09/08/2004 | CN1527882A Supersecretable peptides, processes for their production, and parallel improvement of the secreted form of one or more other polypeptides |
09/08/2004 | CN1527879A Nucleic acid and protein sequences of bovine epidermal growth factor |
09/08/2004 | CN1527878A Shingolipid ceramide deacylase gene |
09/08/2004 | CN1527726A Conjugates of erythropoietin (PEP) with polyethylene glycol (PEG) |
09/08/2004 | CN1527721A Compositions comprising mixtures of human cytokines and methods of producing the same |
09/08/2004 | CN1527720A Global analysis of protein activities using proteome chips |
09/08/2004 | CN1526821A New glucoamylase and coding its nucleic acid sequence |
09/08/2004 | CN1526820A Promotor for expressing gene in fungal cell |
09/08/2004 | CN1526732A Process for producing high pureness albumin solution |
09/08/2004 | CN1526726A Multisite mutant of human histiotype plasminogen activator |
09/08/2004 | CN1165764C Anti PSMA antibody or antigen binding part, and their use |
09/08/2004 | CN1165618C Polynucleotide immunogenic agents |
09/08/2004 | CN1165547C Novel lantibiotic related to actagardine, and process for preparation and use thereof |
09/08/2004 | CN1165344C Compsns. and methods for catalyzing hydrolysis of HIV gp120 |
09/08/2004 | CN1165340C Cartilage/bone inducing materials for reparation |
09/08/2004 | CN1165303C DNA binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
09/07/2004 | US6788182 Metalized polyester film with heat-seal layer on opposite side for flyback transformer application |
09/07/2004 | US6787643 Nucleic acid for use in kits for detection of preferential bacterial infection |
09/07/2004 | US6787641 Identification of sel-12 and uses thereof |
09/07/2004 | US6787639 Collectin |
09/07/2004 | US6787634 Recognizes the extracellular domain of the human ifn-r and which has neutralizing capacity against the biological properties of human type i-ifn. |
09/07/2004 | US6787351 Composition for the prevention of preferential viral infections |
09/07/2004 | US6787346 Kinase capable of site-specific phosphorylation of IκBα |
09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
09/07/2004 | US6787309 Nucleotide sequences coding cardiovascular protein for use in the diagnosis and treatment chromosomal disorder |
09/07/2004 | US6787168 Peptide product |
09/07/2004 | US6787141 Peptide having for fibrinogen fragment E activity, analogs, antibodies and uses thereof |
09/07/2004 | US6787137 Campylobacter vaccine |
09/07/2004 | CA2087006C Nucleic sequences from the genome of salmonella typhi, and uses thereof particularly for the in vitro diagnosis of the presence of salmonella bacteria in foodstuffs |
09/02/2004 | WO2004074498A2 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells |
09/02/2004 | WO2004074497A2 Endomannosidases in the modification of glycoproteins in eukaryotes |
09/02/2004 | WO2004074488A1 Use of caspase enzymes for maturation of engineered recombinant polypeptide fusions |
09/02/2004 | WO2004074461A2 Production of modified glycoproteins having multiple antennary structures |
09/02/2004 | WO2004074458A2 N-acetylglucosaminyltransferase iii expression in lower eukaryotes |
09/02/2004 | WO2004074452A2 Multiplex mapping of protein interactions |
09/02/2004 | WO2004074446A2 Parkin interacting polypeptides and methods of use |
09/02/2004 | WO2004074432A2 Antibody vaccine conjugates and uses therefor |
09/02/2004 | WO2004073393A2 Immunogene adherence and method of making and using same |
09/02/2004 | WO2004053076A3 Methods for rapid detection and identification of bioagents for environmental and product testing |
09/02/2004 | WO2004046365A3 Interferon-alpha polypeptides and conjugates |
09/02/2004 | WO2004036258A3 Screening antibodies using an optical fiber array device capable of simultaneously performing multiple functional assays |
09/02/2004 | WO2004022717A3 Minimally immunogenic variants of humanized col-1 antibody against carcinoembryonic antigen |
09/02/2004 | WO2004020456A3 Selecting therapeutic human monoclonal antibodies from disease-specific libraries |
09/02/2004 | WO2003048302A3 Identifying anti-tumor targets or agents by lipid raft immunization and proteomics |
09/02/2004 | WO2003015697A3 Interleukin-2 mutants with reduced toxicity |
09/02/2004 | US20040172687 Modified proteinase inhibitors |
09/02/2004 | US20040172676 Transforming cells with expression vector comprising early nodulin gene-2 (ENOD2) promoter for use as tissue specific gene regulatory tool; bioreactors and heterologous gene expression |
09/02/2004 | US20040172673 Expression vector comprising nucleotide sequences coding polypetide which confers resistance to pseudomonas syringae; genetic engineering and disease resistant plants |
09/02/2004 | US20040172670 Maize yellow stripe1 and related genes |
09/02/2004 | US20040171826 Endomannosidases in the modification of glycoproteins in eukaryotes |
09/02/2004 | US20040171806 Modified hpv e6 and e7 genes and proteins useful for vaccination |
09/02/2004 | US20040171803 Artificial protein having potentiated immunogenicity of epitope |
09/02/2004 | US20040171802 Haemophilus influenzae antigens and corresponding dna fragments |
09/02/2004 | US20040171800 Gamma retinoic acid receptor |
09/02/2004 | US20040171551 which binds to an amino acid sequence comprising at least 5 EP motifs over a 19 amino acid segment |
09/02/2004 | US20040171538 Anticoagulants and their uses |
09/02/2004 | US20040171120 Enhanced insecticidal protein for killing bettles, moths, flies; biolgical pest control |
09/02/2004 | US20040171117 Anti-RANK ligand monoclonal antibodies useful in treatment of RANK ligand mediated disorders |
09/02/2004 | US20040171113 Antigens of group b streptococcus and corresponding dna fragments |
09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
09/02/2004 | US20040171105 Using enzymatic polypeptide to inactivate inhibitor of apoptosis and activate caspase for treatment and prevention of cancer, autoimmune and neurodegenerative diseases |